Summit Corp. PLC | Key People and Executives
Glyn O. Edwards
Chief Executive Officer & Executive Director
Frank Murdoch Armstrong
Non-Executive Chairman
David M. Wurzer
Independent Non-Executive Director
Stephen Graham Davies
Independent Non-Executive Director
Valerie Lynne Andrews
Independent Non-Executive Director
Leopoldo Giampaolo Zambeletti
Independent Non-Executive Director
Barry James Price
Independent Non-Executive Director
Glyn O. Edwards
Chief Executive Officer & Executive Director
David Roblin
Chief Operating & Medical Officer
Erik Ostrowski
Chief Financial Officer
Jonathon Tinsley
Chief Scientific Officer-DMD
Richard Pye
Senior Director-Corporate Affairs & Communications
Michelle Avery
Director-Investor Relations
Melissa Strange
Secretary
Frank Murdoch Armstrong
Non-Executive Chairman
David M. Wurzer
Independent Non-Executive Director
Stephen Graham Davies
Independent Non-Executive Director
Valerie Lynne Andrews
Independent Non-Executive Director
Leopoldo Giampaolo Zambeletti
Independent Non-Executive Director
Barry James Price
Independent Non-Executive Director
| Address |
136a Eastern Avenue
Abingdon Oxfordshire OX14 4SB
United Kingdom
|
|
Employees
|
- |
| Website |
http://summitplc.com |
| Updated |
07/08/2019 |
| Summit Therapeutics Plc is a holding company, which engages in the discovery, development, and commercialization of novel medicines. It focuses on the genetic disease duchenne muscular dystrophy, and the infectious disease clostridium difficile infection. The company was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, United Kingdom. |
